Manuka, Inc. (MNKA)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 15, 2025
-95.24%
Market Cap 11.20K
Revenue (ttm) 672.00K
Net Income (ttm) -1.14M
Shares Out 112.03M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 390
Average Volume 4,635
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range 0.0000 - 0.0001
Beta -103.30
RSI 34.92
Earnings Date Nov 21, 2025

About Manuka

Manuka, Inc. provides skincare products in Israel. It offers anti-aging eye cream, vitamin C serum, bee venom anti-aging serum, plant stem cell serum with hyaluronic acid, anti-aging day cream with manuka honey and bee venom, restorative night cream with manuka honey and bee venom, and facial gel and soap, as well as package sets. The company is based in Petah Tikva, Israel. [Read more]

Founded 2020
Employees 4
Stock Exchange OTCMKTS
Ticker Symbol MNKA
Full Company Profile

Financial Performance

In 2022, Manuka's revenue was $311,000, an increase of 4342.86% compared to the previous year's $7,000. Losses were -$1.36 million, 311.9% more than in 2021.

Financial Statements

News

There is no news available yet.